Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript

23 hours ago · Trinity Biotech Plc (NASDAQ:TRIB) Q3 2024 Earnings Conference Call November 15, 2024 10:00 AM ET. Company Participants. Eric Ribner - Investor Relations John Gillard – …

CouponFollow Extension

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - Yahoo Finance

2 weeks from now

9 hours ago · Trinity Biotech plc. Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business. Point-of-Care product revenue of …

yahoo.com

$0.46
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · The basic and diluted loss per ADS for Q3 2024 was $0.46 compared to $1.55 in Q3 2023. Liquidity. The Group’s cash balance decreased to $2.8m at the end of Q3 2024 from …

globenewswire.com

$15
OFF

Trinity Biotech : Announces Q3 2024 Financial Results Form 6 K

2 weeks from now

4 hours ago · Earnings Flash (TRIB) TRINITY BIOTECH Posts Q3 Revenue $15.2M 11:35am: MT Trinity Biotech plc, Q3 2024 Earnings Call, Nov 15, 2024 10:00am: European Equities Traded …

marketscreener.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 million grew 60% …

businessinsider.com

$15
OFF

Earnings Flash (TRIB) TRINITY BIOTECH Posts Q3 Revenue $15.2M

2 weeks from now

6 hours ago · Earnings Flash (TRIB) TRINITY BIOTECH Posts Q3 Revenue $15.2M 11:35am: MT Trinity Biotech plc, Q3 2024 Earnings Call, Nov 15, 2024 10:00am: European Equities Traded …

marketscreener.com

$0.55
OFF

Trinity Biotech (TRIB) Earnings Date And Reports 2024 - MarketBeat

2 weeks from now

Trinity Biotech released Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.55, which beat the consensus estimate of -$0.65 by $0.10. Quarterly revenue was reported to be $15.84 …

marketbeat.com

3%
OFF

Trinity Biotech Announces Q3 2024 Financial Results - GuruFocus

2 weeks from now

Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV business Point-of-Care product revenue of $4.3 mill ... Insider Transaction …

gurufocus.com

$20
OFF

Trinity Biotech Announces Q3 2024 Financial Results

2 weeks from now

9 hours ago · Reiterates guidance to achieve approximately $20 million of annualized run-rate EBITDASO 1 on annualized run-rate revenues of approximately $75 million by Q2 2025. …

marketscreener.com

FAQs about Trinity Biotech Plc (TRIB) Q3 2024 Earnings Call Transcript Coupon?

What time is Trinity biotech Q4 2023 earnings conference call?

Trinity Biotech plc (NASDAQ:TRIB) Q4 2023 Earnings Conference Call April 4, 2024 8:00 AM ET Company Participants John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financial Officer Eric R... ...

Does Trinity biotech (Trib) stock rise post-market?

Trinity stock soars post-market on raised guidance, increased capacity SA NewsMon, Aug. 26 Trinity Biotech plc (TRIB) Q2 2024 Earnings Call Transcript SA TranscriptsFri, Aug. 16 Trinity Biotech reports Q2 results SA NewsWed, Aug. 14 Trinity Biotech obtains extension to demonstrate compliance with Nasdaq listing requirements SA NewsTue, Aug. 06 ...

What did Trinity biotech do in 2024?

DUBLIN, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended September 30, 2024. Key Highlights and Developments ...

How much did Trinity biotech make in a quarter?

Trinity Biotech plc (NASDAQ:TRIB) issued its earnings results on Wednesday, August, 14th. The company reported ($0.55) EPS for the quarter, beating analysts' consensus estimates of ($0.65) by $0.10. The firm earned $15.84 million during the quarter, compared to analysts' expectations of $15.75 million. When did Trinity Biotech's stock split? ...

Who owns Trinity Biotech stock?

In the past three months, Trinity Biotech insiders have not sold or bought any company stock. Only 8.20% of the stock of Trinity Biotech is held by insiders. 78.97% of the stock of Trinity Biotech is held by institutions. High institutional ownership can be a signal of strong market trust in this company. ...

Why did our haemoglobins Division perform better in Q3 2024?

We continued to record improved margins in our haemoglobins division in Q3 2024 due to the financial benefits resulting from our previously announced initiatives, namely our revised in-house manufacturing process of our key diabetes HbA1c consumable. ...